Literature DB >> 28052161

Rate of Statin Prescription in Younger Patients With Severe Dyslipidemia.

Sadeer G Al-Kindi1, Anthony DeCicco1, Chris T Longenecker1, Jarrod Dalton2, Daniel I Simon1, David A Zidar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28052161      PMCID： PMC6787925          DOI： 10.1001/jamacardio.2016.5162

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  6 in total

1.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

2.  Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts.

Authors:  Joshua W Knowles; Neil J Stone; Christie M Ballantyne
Journal:  Am J Cardiol       Date:  2015-05-09       Impact factor: 2.778

3.  Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.

Authors:  N J Stone; R I Levy; D S Fredrickson; J Verter
Journal:  Circulation       Date:  1974-03       Impact factor: 29.690

4.  Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.

Authors:  Lawrence D Lazar; Mark J Pletcher; Pamela G Coxson; Kirsten Bibbins-Domingo; Lee Goldman
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

5.  Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.

Authors:  Dhruv S Kazi; Andrew E Moran; Pamela G Coxson; Joanne Penko; Daniel A Ollendorf; Steven D Pearson; Jeffrey A Tice; David Guzman; Kirsten Bibbins-Domingo
Journal:  JAMA       Date:  2016-08-16       Impact factor: 56.272

Review 6.  Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.

Authors:  Melissa A Austin; Carolyn M Hutter; Ron L Zimmern; Steve E Humphries
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897
  6 in total
  8 in total

Review 1.  Evolution and Outcomes of Premature Coronary Artery Disease.

Authors:  Cara Lea Smith; Matthew Seigerman; Srinath Adusumalli; Jay Giri; Paul N Fiorilli; Daniel M Kolansky; Taisei Kobayashi
Journal:  Curr Cardiol Rep       Date:  2021-03-08       Impact factor: 2.931

2.  Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country.

Authors:  Anne Thushara Matthias; Jayamini Kaushalya; Gayasha Somathilake; Chaminda Garusinghe
Journal:  Int J Diabetes Dev Ctries       Date:  2022-07-07

3.  Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).

Authors:  Emily M Bucholz; Angie Mae Rodday; Katherine Kolor; Muin J Khoury; Sarah D de Ferranti
Journal:  Circulation       Date:  2018-03-26       Impact factor: 29.690

4.  The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey.

Authors:  Fu-Liang Zhang; Ying-Qi Xing; Yan-Hua Wu; Hao-Yuan Liu; Yun Luo; Ming-Shuo Sun; Zhen-Ni Guo; Yi Yang
Journal:  Lipids Health Dis       Date:  2017-03-23       Impact factor: 3.876

5.  Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice.

Authors:  Mohamed Anwar Hammad; Syed Azhar Syed Sulaiman; Nor Azizah Aziz; Dzul Azri Mohamed Noor
Journal:  J Res Med Sci       Date:  2019-02-25       Impact factor: 1.852

6.  Lower-Intensity Statins Contributing to Gaps in Care for Patients With Primary Severe Hypercholesterolemia.

Authors:  Wael E Eid; Emma Hatfield Sapp; Elijah Flerlage; Joseph R Nolan
Journal:  J Am Heart Assoc       Date:  2021-09-01       Impact factor: 5.501

7.  Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults.

Authors:  Su-Min Jeong; Seulggie Choi; Kyuwoong Kim; Sung Min Kim; Gyeongsil Lee; Seong Yong Park; Yeon-Yong Kim; Joung Sik Son; Jae-Moon Yun; Sang Min Park
Journal:  J Am Heart Assoc       Date:  2018-06-13       Impact factor: 5.501

8.  The evaluation and management of patients with LDL-C ≥ 190 ​mg/dL in a large health care system.

Authors:  Candace L Jackson; Zahid Ahmad; Sandeep R Das; Amit Khera
Journal:  Am J Prev Cardiol       Date:  2020-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.